These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8132440

  • 21. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.
    Hudson JI, McElroy SL, Raymond NC, Crow S, Keck PE, Carter WP, Mitchell JE, Strakowski SM, Pope HG, Coleman BS, Jonas JM.
    Am J Psychiatry; 1998 Dec; 155(12):1756-62. PubMed ID: 9842788
    [Abstract] [Full Text] [Related]

  • 22. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.
    McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH.
    Arch Gen Psychiatry; 1996 Nov; 53(11):1001-8. PubMed ID: 8911223
    [Abstract] [Full Text] [Related]

  • 23. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
    Mundo E, Guglielmo E, Bellodi L.
    Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
    [Abstract] [Full Text] [Related]

  • 24. Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases.
    Horii A, Uno A, Kitahara T, Mitani K, Masumura C, Kizawa K, Kubo T.
    J Vestib Res; 2007 Sep; 17(1):1-8. PubMed ID: 18219099
    [Abstract] [Full Text] [Related]

  • 25. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

  • 26. Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder.
    Heidari M, Zarei M, Hosseini SM, Taghvaei R, Maleki H, Tabrizi M, Fallah J, Akhondzadeh S.
    Int Clin Psychopharmacol; 2014 Nov; 29(6):344-50. PubMed ID: 24850229
    [Abstract] [Full Text] [Related]

  • 27. A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder.
    Turkington D, Grant JB, Ferrier IN, Rao NS, Linsley KR, Young AH.
    J Clin Psychiatry; 2002 Sep; 63(9):778-81. PubMed ID: 12363117
    [Abstract] [Full Text] [Related]

  • 28. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
    Zohar J, Keegstra H, Barrelet L.
    Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
    [Abstract] [Full Text] [Related]

  • 29. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP, Boyer WF, Meredith CH, Hendrickson GG.
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [Abstract] [Full Text] [Related]

  • 30. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.
    Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
    [Abstract] [Full Text] [Related]

  • 31. [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin].
    Riesner HJ, Zeitler C, Schreiber H, Wild A.
    Z Orthop Unfall; 2008 May; 146(6):742-6. PubMed ID: 19085723
    [Abstract] [Full Text] [Related]

  • 32. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
    Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.
    J Clin Psychiatry; 2003 Jun; 64(6):640-7. PubMed ID: 12823077
    [Abstract] [Full Text] [Related]

  • 33. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D, Serretti A, Franchini L, Mandelli L, Smeraldi E, De Ronchi D, Zanardi R.
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T, Ikeda A, Ueki M.
    J Med; 2004 Oct; 35(1-6):151-62. PubMed ID: 18084873
    [Abstract] [Full Text] [Related]

  • 35. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
    Ciaramella A, Grosso S, Poli P.
    Minerva Anestesiol; 2000 Oct; 66(1-2):55-61. PubMed ID: 10736983
    [Abstract] [Full Text] [Related]

  • 36. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C, Kapik B, Flanders WD.
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [Abstract] [Full Text] [Related]

  • 37. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients.
    Rahman MK, Akhtar MJ, Savla NC, Sharma RR, Kellett JM, Ashford JJ.
    Br J Clin Pract; 1991 Sep; 45(4):255-8. PubMed ID: 1810358
    [Abstract] [Full Text] [Related]

  • 38. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study.
    Zanardi R, Franchini L, Gasperini M, Lucca A, Smeraldi E, Perez J.
    J Clin Psychopharmacol; 1998 Dec; 18(6):441-6. PubMed ID: 9864075
    [Abstract] [Full Text] [Related]

  • 39. Chronic muscle contraction headache: the importance of depression and anxiety.
    Hackett GI, Boddie HG, Harrison P.
    J R Soc Med; 1987 Nov; 80(11):689-91. PubMed ID: 3320366
    [Abstract] [Full Text] [Related]

  • 40. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
    Dalery J, Honig A.
    Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.